Home › Squamous Cell Carcinoma › Pennsylvania › Philadelphia
Squamous Cell Carcinoma clinical trials in Philadelphia, PA
3 studies for Squamous Cell Carcinoma are looking for participants at sites in and around Philadelphia (within about 30 miles). Open a study to see who can join and how to contact the study team.
JNJ-90301900 (NBTXR3) Activated by Radiotherapy With or Without Cetuximab in LA-HNSCC
RecruitingPhase 3
- University of Pennsylvania Perelman Center for Advanced Medicine, Philadelphia
Intratumoral Lidocaine Injection Before Oropharyngeal Cancer Surgery
RecruitingPhase 1
- Abramson Cancer Center at University of Pennsylvania, Philadelphia
A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
RecruitingPhase 3
- Fox Chase Cancer Center, Philadelphia
Squamous Cell Carcinoma trials in other cities
- Pittsburgh, PA10 studies
- Los Angeles, CA8 studies
- Boston, MA8 studies
- New York City, NY7 studies
- Nashville, TN7 studies
- Houston, TX7 studies
- Atlanta, GA5 studies
- Queens, NY4 studies
- Durham, NC4 studies
- Arlington, VA4 studies
- Washington, DC4 studies
- Dallas, TX4 studies
Other studies in Philadelphia
- Cancer (all types)60 studies
- Breast Cancer56 studies
- Non-Small Cell Lung Cancer51 studies
- Metastatic Cancer46 studies
- Colorectal Cancer44 studies
- Ovarian Cancer44 studies
- Prostate Cancer44 studies
- Lung Cancer36 studies
- Acute Myeloid Leukemia34 studies
- Heart Failure31 studies
- Endometrial Cancer29 studies
- Pancreatic Cancer26 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.